Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for ischemic cardiomyopathy (Follow-up trial)

JRCT ID: jRCT2053220055

Registered date:22/06/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Ischemic cardiomyopathy
• Date of first enrollment: 22/06/2022
• Target sample size: 10
• Study type: Observational

Outcome(s)

• Primary Outcome: Lifetime

Secondary Outcome

1) Number and rate of clinical events of cardiac function such as death and hospitalization
2) Number and rate of tumor development events

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1) Patients who have undergone iPS cell derived-cardiomyocyte sheet (Clinical trial identification code:IPSOC-1) transplantation
2) Patients who can obtain concent to participate in this trial

• Exclude criteria: none

Related Information

• Primary Sponsor: Miyagawa Shigeru
• Source(s) of Monetary Support: Cuorips Inc.